Tempo Therapeutics is a biotechnology and tissue engineering company based in San Diego, CA, dedicated to speeding up patient recovery. With its pioneering MAP material science technology, Tempo Therapeutics is at the forefront of a new era in tissue engineering biotechnology. Their core technology, called Microporous Annealed Particle (MAP), enables them to create fully synthetic and precision engineered injectable materials that can modulate a patient's own immune cells, driving biological responses.

Through MAP technology, they are actively building functional tissue and organs within patients to treat various diseases. Tempo Therapeutics' leading biosurgery products are specifically designed to address significant clinical challenges in patients undergoing abdominal laparotomy for surgical oncology, as well as patients with complex surgical sites from diabetic limb salvage and trauma. By building new vascular tissue in these patients, their products enhance tissue strength and restore function, ultimately improving outcomes and saving lives.

In addition to biosurgery products, Tempo Therapeutics is also focused on developing combination drug delivery, allogenic cell engraftment, and next-generation vaccine technologies. They have assembled a team of dedicated scientists, physicians, and engineers who are committed to developing novel therapies based on MAP technology. Tempo Therapeutics actively collaborates and builds strategic relationships to expand their therapeutic areas and utilize tissue engineering to improve the lives of patients in need.

To learn more about Tempo Therapeutics' proprietary MAP material science technology, you can contact them today